# Nirmatrelvir-and-severe-disease
Analysis scripts examining impact of nirmatrelvir on preventing severe COVID. Published as 'Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study',  Dryden-Peterson S et al. Annals of Internal Medicine, 2023. https://doi.org/10.7326/M22-2141
